Salimah, K., Hardianti, M. S., Anggorowati, N., & Taroeno-Hariadi, K. (2026). Co-expression of BCL2 and C-MYC as a Potential Predictive Factor of Survival in Diffuse Large B Cell Lymphoma with Rituximab-Based Chemotherapy. Asian Pacific Journal of Cancer Biology, 11(1), 23-29. https://doi.org/10.31557/apjcb.2026.11.1.23-29